<DOC>
	<DOC>NCT00227188</DOC>
	<brief_summary>The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)</brief_summary>
	<brief_title>Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>All children from 0 up to 5 years attending to the hospital's emergency department will be evaluated for IPD. Diagnosis of IPD will be based on positive pneumococcal isolation in any sterile location, such us blood or spinal fluid.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>